Stax Provides Sell-Side Support to BioProcure-Prendio, Receiving Strategic Growth Investment from Primus Capital

Stax Provides Sell-Side Support to BioProcure-Prendio, Receiving Strategic Growth Investment from Primus Capital

November 3, 2023
November 3, 2023

Share

Stax is pleased to congratulate BioProcure and its sister company, Prendio, on their recent growth equity investment from Primus Capital. Stax provided sell-side support collaborating with the management teams of BioProcure and Prendio and Aeris Partners.


Since 2007, BioProcure has significantly contributed to the success of numerous global life science companies. An industry-leading provider of procure-to-pay enabled services for biotech, BioProcure offers procurement services, accounts payable support, and administrative assistance to research organizations. 

 

Prendio is a leading provider of cloud-based eProcurement SaaS and supplier marketplace solutions tailored for the life science sector. Developed by a team with over 50 years of experience in biotech procurement and lab management, Prendio software addresses the challenges faced by research teams dealing with complex procure-to-pay systems. It offers an affordable, user-friendly, and scalable solution, ultimately speeding up the progress of life science teams. 

For more details on our experience in the space, please contact the Stax team: 

BioProcure-Prendio logo
Primus logo
BioProcure-Prendio logo
Primus logo

For more details on our experience in the space, please contact the Stax team: 

Image of Rob Larson

Paul Edwards

Global Practice Lead

Image of Rob Larson

Rob Larson

Director

About Stax

Stax is a global management consulting firm serving corporate and private equity clients across a broad range of industries including software/technology, industrials, business and information services, healthcare and HCIT, consumer, and tradeshows and events. 

Read More

Will Barden Named Among The Consulting Report’s Top 25 Strategy Leaders of 2025
By Will Barden December 11, 2025
Will Barden, Partner, has been named among "The Consulting Report's" Top 25 Strategy Leaders of 2025. Click here to read more about the award.
Investing in Pharma Technology: A Healthcare Breakfast Discussion
By Rob Larson & Jordan Abrams December 8, 2025
In partnership with Raymond James and Farragut Square Group, Grant Thornton Stax recently hosted a breakfast event to share our investment analysis of the Pharma Technology market.
Miriam El-Baz & Connor Novy Honored as Consulting Magazine Women Leaders
December 2, 2025
Miriam El-Baz and Connor Novy were recognized at the Consulting Magazine Women Leaders awards to highlight the outstanding contributions made by women in consulting. Read more.
Featured in Financier Worldwide—Accelerating value in PE carve-outs: strategy and execution
By Phil Dunne & Peter Rodrigues-Renon November 11, 2025
Financier Worldwide discusses strategy & execution for accelerating value in carve-outs with Phil Dunne and Peter Rodrigues-Renon at Stax, including Gerard Nichol at Grant Thornton. Read more.
Key Considerations for Investors Exploring the Automotive Retail Tech Value Chain
By Sameer Tejani & Max Massaro November 6, 2025
Investment focus in automotive technology continues to broaden beyond OEMs to the core service ecosystem. Read what Sameer Tejani and Max Massaro see in the market.
Grant Thornton Stax Provides Sell-Side Support to SteelEye on its Merger With FundApps​
November 3, 2025
Grant Thornton Stax supported SteelEye, a leading trade and communications surveillance and data analytics platform, on its recent merger with FundApps. Read about the deal here.
Show More